David Fitchett

2.5k total citations · 2 hit papers
24 papers, 1.8k citations indexed

About

David Fitchett is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, David Fitchett has authored 24 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 10 papers in Surgery and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in David Fitchett's work include Diabetes Treatment and Management (6 papers), Acute Myocardial Infarction Research (6 papers) and Cardiac Imaging and Diagnostics (5 papers). David Fitchett is often cited by papers focused on Diabetes Treatment and Management (6 papers), Acute Myocardial Infarction Research (6 papers) and Cardiac Imaging and Diagnostics (5 papers). David Fitchett collaborates with scholars based in Canada, United States and Germany. David Fitchett's co-authors include Raymond P. Kelly, Ross T. Tsuyuki, Charmaine E. Lok, Sophie A. Jamal, David C. Mendelssohn, Christoph Wanner, Bernard Zinman, Jyothis T. George, Silvio E. Inzucchi and Ben Vandermeer and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

David Fitchett

24 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease

2017 340 citations Christoph Wanner, John M. Lachin et al. Circulation profile →
Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis

2013 316 citations Sophie A. Jamal, Ben Vandermeer et al. The Lancet profile →

Peers

David Fitchett

CCM

SURGE

NEPHR

EDM

MB

Nicola C. Edwards United Kingdom

Thomas Stefenelli Austria

Charalampos Loutradis Greece

Kayo Shinohara Japan

Marcel Lebel Canada

Roger Rennenberg Netherlands

Jan Dirk Banga Netherlands

Michael Kapeliovich Israel

Nobuhiko Joki Japan

Nicola C. Edwards United Kingdom

David Fitchett

1.5k ×1.8

CCM

428 ×0.8

SURGE

661 ×1.5

NEPHR

378 ×1.0

EDM

246 ×0.9

MB

Citations per year, relative to David Fitchett David Fitchett (= 1×) peers Nicola C. Edwards

Countries citing papers authored by David Fitchett

Since Specialization

Citations

This map shows the geographic impact of David Fitchett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Fitchett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Fitchett more than expected).

Fields of papers citing papers by David Fitchett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Fitchett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Fitchett. The network helps show where David Fitchett may publish in the future.

Co-authorship network of co-authors of David Fitchett

This figure shows the co-authorship network connecting the top 25 collaborators of David Fitchett. A scholar is included among the top collaborators of David Fitchett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Fitchett. David Fitchett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Sharma, Abhinav, Silvio E. Inzucchi, Jeffrey M. Testani, et al.. (2023). Kidney and Heart Failure Events are Bidirectionally Associated in Patients with Type 2 Diabetes and Cardiovascular Disease. ESC Heart Failure. 11(2). 737–747. 9 indexed citations

2.

Böhm, Michael, David Fitchett, Anne Pernille Ofstad, et al.. (2020). Heart failure and renal outcomes according to baseline and achieved blood pressure in patients with type 2 diabetes: results from EMPA-REG OUTCOME. Journal of Hypertension. 38(9). 1829–1840. 20 indexed citations

3.

Wanner, Christoph, John M. Lachin, Silvio E. Inzucchi, et al.. (2017). Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease. Circulation. 137(2). 119–129. 340 indexed citations breakdown →

4.

Schou, Morten, Lars Gullestad, David Fitchett, et al.. (2017). Abstract 15997: Empagliflozin Exerts Short- and Long-term Effects on Plasma Volume in Patients With Type 2 Diabetes: Insight From EMPA-REG OUTCOME. Circulation. 1 indexed citations

5.

Goodman, Shaun G., Raymond T. Yan, José López-Sendón, et al.. (2013). Management and Outcomes of Non-ST Elevation Acute Coronary Syndromes in Relation to Previous Use of Antianginal Therapies (from the Canadian Global Registry of Acute Coronary Events [GRACE] and Canadian Registry of Acute Coronary Events [CANRACE]). The American Journal of Cardiology. 112(1). 51–56. 6 indexed citations

6.

Jamal, Sophie A., Ben Vandermeer, Paolo Raggi, et al.. (2013). Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. The Lancet. 382(9900). 1268–1277. 316 indexed citations breakdown →

7.

Fitchett, David. (2012). Potential role of rivaroxaban in patients with acute coronary syndrome. Drug Design Development and Therapy. 6. 349–349. 2 indexed citations

8.

Jamal, Sophie A., David Fitchett, Charmaine E. Lok, David C. Mendelssohn, & Ross T. Tsuyuki. (2009). The effects of calcium-based versus non-calcium-based phosphate binders on mortality among patients with chronic kidney disease: a meta-analysis. Nephrology Dialysis Transplantation. 24(10). 3168–3174. 65 indexed citations

9.

Cantor, Warren J., David Fitchett, Bjug Borgundvaag, et al.. (2009). Routine Early Angioplasty after Fibrinolysis for Acute Myocardial Infarction. New England Journal of Medicine. 360(26). 2705–2718. 346 indexed citations

10.

Stewart, Duncan J., Michael J.B. Kutryk, David Fitchett, et al.. (2009). VEGF Gene Therapy Fails to Improve Perfusion of Ischemic Myocardium in Patients With Advanced Coronary Disease: Results of the NORTHERN Trial. Molecular Therapy. 17(6). 1109–1115. 195 indexed citations

11.

Casanova, Amparo, et al.. (2008). Clinical implications of a next-day follow-up electrocardiogram in patients with non-ST elevation acute coronary syndromes. American Heart Journal. 156(4). 797–803. 4 indexed citations

12.

Fitchett, David. (2008). Results of the ONTARGET and TRANSCEND studies: an update and discussion. Vascular Health and Risk Management. 5(1). 21–21. 19 indexed citations

13.

Cantor, Warren J., Richard Choi, Michael Heffernan, et al.. (2006). Transfer for urgent percutaneous coronary intervention early after thrombolysis for ST-elevation myocardial infarction: The TRANSFER-AMI pilot feasibility study. Canadian Journal of Cardiology. 22(13). 1121–1126. 16 indexed citations

14.

Levy, Adrian R., Robyn Tamblyn, Michał Abrahamowicz, Peter J. McLeod, & David Fitchett. (2004). Use of time‐dependent measures to estimate benefits of β‐blockers after myocardial infarction. Pharmacoepidemiology and Drug Safety. 13(9). 623–631. 7 indexed citations

15.

Levy, Adrian R., Robyn Tamblyn, Peter J. McLeod, David Fitchett, & Michał Abrahamowicz. (2002). The Effect of Physicians' Training on Prescribing β-Blockers for Secondary Prevention of Myocardial Infarction in the Elderly. Annals of Epidemiology. 12(2). 86–89. 12 indexed citations

16.

Goodman, Shaun G., Aiala Barr, Anatoly Langer, et al.. (2002). Development and prognosis of non-Q-wave myocardial infarction in the thrombolytic era. American Heart Journal. 144(2). 243–250. 22 indexed citations

17.

Goodman, Shaun G., Aiala Barr, Anatoly Langer, et al.. (2002). Development and prognosis of non-Q-wave myocardial infarction in the thrombolytic era. American Heart Journal. 144(2). 243–250. 13 indexed citations

18.

Kuliszewski, Michael A., Michael J.B. Kutryk, Reena Sandhu, David Fitchett, & Duncan J. Stewart. (2000). DNA integrity and transgene expression after passage through the NOGA needle catheter used for therapeutic myocardial angiogenesis. PubMed. 3(3). 167–172. 1 indexed citations

19.

Ramos‐Barbón, David, et al.. (1999). Maximal Exercise Testing for the Selection of Heart Transplantation Candidates. CHEST Journal. 115(2). 410–417. 19 indexed citations

20.

Kelly, Raymond P. & David Fitchett. (1992). Noninvasive determination of aortic input impedance and external left ventricular power output: A validation and repeatability study of a new technique. Journal of the American College of Cardiology. 20(4). 952–963. 282 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact